Development of a Quantitative Multiplex Assay to Detect ALK Fusion Transcript in Lung CancerTuesday, 25 September 2012 at 09:30 Add to Calendar ▼2012-09-25 00:00:002012-09-25 01:00:00Europe/LondonMolecular Diagnostics World Congress in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com We developed a single multiplex assay for ALK fusion detection by simultaneously interrogating for presence of ALK fusion transcripts and ALK over-expression. The assay is highly sensitive, specific, easy to perform, and suitable for screening large numbers of tumor samples. |